Genetic Technologies (GENE)
(Delayed Data from NSDQ)
$0.77 USD
-0.04 (-4.46%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $0.83 +0.06 (7.24%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Genetic Technologies Ltd falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | |
---|---|---|---|---|---|
Sales | NA | 6 | 5 | 0 | 0 |
Cost Of Goods | NA | 3 | 2 | 0 | 0 |
Gross Profit | NA | 3 | 3 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 7 | 4 | 5 | 5 |
Income After Depreciation & Amortization | 0 | -4 | -1 | -5 | -5 |
Non-Operating Income | NA | 4 | 4 | 0 | 1 |
Interest Expense | NA | 0 | 0 | 0 | 0 |
Pretax Income | NA | -8 | -5 | -5 | -4 |
Income Taxes | NA | 0 | 0 | 0 | 0 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -8 | -5 | -5 | -4 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | -8 | -5 | -5 | -4 |
Depreciation Footnote | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | -4 | -1 | -5 | -5 |
Depreciation & Amortization (Cash Flow) | NA | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | 0 | -4 | -1 | -5 | -5 |
Earnings Per Share Data | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Average Shares | NA | 3.38 | 3.07 | 2.85 | 1.39 |
Diluted EPS Before Non-Recurring Items | NA | -2.35 | -1.70 | -1.80 | -2.95 |
Diluted Net EPS (GAAP) | NA | -2.34 | -1.69 | -1.79 | -3.00 |
Fiscal Year end for Genetic Technologies Ltd falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |